Hemolysate-mediated renal vasoconstriction and hypersensitization

Renal Failure

Volumn 21, Issue 1, 1999, Pages 23-33

  Burke, Thomas J ^a   Falk, Sandor ^b   Conger, John D ^b   Voelkel, Norbert F ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Afferent arteriole; Efferent arteriole; Fluorescence; Fura 2; Kidney; Renal vascular resistance; VSMC

Indexed keywords

ANGIOTENSIN; CALCIUM; HEMOGLOBIN;

ANAPHYLAXIS; ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL DIAMETER; CALCIUM CELL LEVEL; CONTROLLED STUDY; HEMOLYSATE; HEMOLYSIS; HUMAN; HUMAN CELL; KIDNEY VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0033049043     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229909066967     Document Type: Article

References (28)

1. th Ed. Little Brown and Co, Boston, MA, 1993, pp 1555-1643.
2. Haynes JJ., Taylor AE, Dixon D, Voelkel N: Microvascular hemodynamics in the sickle red blood cell perfused isolated rat lung. Am. J Physiol 264:R484-H489, 1993.
3. Matz P, Weinstein P, States B, Honkaniemi J, Sharp FR: Subarachnoid injections of lysed blood induce the hsp70 stress gene and produce DNA fragmentation in focal areas of the rat brain. Stroke 27:504-512, 1996.
4. Tippler B, Herbst C, Simmet T: Evidence for the formation of endothelin by lysed red blood cells from endogenous precursor. Europ J Pharmacol 271:131-139, 1994
5. Thomas T, Marshall JM: The role of adenosine in hypoxic pulmonary vasoconstriction in the anaesthetized rat. Exp Physiol 78:541-543, 1993.
6. Voelkel NF, Czartolomna J: Vanadate potentiates hypoxic pulmonary vasoconstriction. J Pharmacol Exp Therapeu 259:666-672, 1991.
7. Aoki T, Takenaka K, Suzuki S, Kassell NF, Sagher O, Lee KS: The role of hemolysate in the facilitation of oxyhemoglobin-induced contraction in rabbit basilar arteries. J Neurosurgery 81:262-266, 1994.
8. Voelkel NF, Lobel K, Westcott JY, Burke TJ: Nitric oxide-related vasoconstriction in lungs perfused with red cell lysate. FASEB J 9:379-386, 1995.
9. Yuan BH, Conger JD: Effects of angiotensin II and norepinephrine on isolated rat afferent and efferent arterioles. Am J Physiol 258(27):F741-F750, 1990.
10. Conger JD, Falk SA: Abnormal vasoreactivity of isolated arterioles from rats with ischemic acute renal failure. J Am Soc Nephrol 4:733A, 1993.
11. Conger JD, Falk SA, Robinette JB: Cytosolic smooth muscle calcium kinetics in the 48-hr post-ischemic renal vasculature. J Am Soc Nephrol 5:895A, 1994.
12. Conger JD, Robinette JB, Hammond WS: Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Intern 39:1087-1097, 1991.
13. Li X, Kribben A, Wieder ED, Tsai P, Nemenoff RA, Schrier RW: Inhibition of vasopressin action in vascular smooth muscle bythe VI antagonist OPC-21268. Hypertension 23:217-222, 1994.
14. Kribben A, Wieder ED, Wetzels IF, Yu L, Gengaro PE, Burke TJ, Schrier RW: Evidence for role of cytosolic free calcium in hypoxia-induced proximal tubule injury. J Clin Invest 93:1922-1929, 1994.
15. Lanese DM, Yuan BH, Falk SA, and Conger JD: The effects of APIII on the isolated afferent and efferent arterioles of the rat kidney. Am J Physiol 261:F1102-F1109, 1991.
16. Edwards RM: Sequential effects of norepenephrine and angiotensin II on isolated renal microvessels. Am J Physio 244: F526-F534, 1983.
17. Conger JD, Falk SA, Robinette JB.:Angiotensin II-induced changes in smooth muscle calcium in rat renal arterioles. J Am Soc Nephrol 3:1792-1803, 1993.
18. 2+i) elevation in cerebral smooth muscle cells. Am J Physiol 269:H1874-H1890, 1995.
19. + antiporter in vascular smooth muscle cells in culture. Kidney Int 45:66-75, 1994.
20. Li X, Tsai P, Wieder ED, Kribben A, Van Putten V, Schfler R W, Nemenoff RA: Vascular smooth muscle cells grown on Matrigel. A model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J Biol Chem 269:19653-19658, 1994.
21. Okada K, Ishikawa S, Caramelo C, Tsai P, Schrier RW: Enhancement of vascular action of arginine vasopressin by diminished extracellular sodium concentration.
22. Hammond D, Lieberman E: The hemolytic uremic syndrome. Renal cortical thrombotic microangiopathy. Arch Intern Med 126:816-822, 1970.
23. Voelkel NF, Allard JD, Anderson SM, Burke TJ: cGMP and cAMP cause pulmonary vasoconstriction in the presence of hemolysate (In press).
24. Thompson A, McGarry AE, Valeri CR, Lieberthal W: Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. J Appl Physiol 77:2348-2354, 1994.
25. Hinman LE, Beilman GJ, Groehler KE, Sammak PJ: Wound-induced calcium waves in alveolar type II cells. Am J Physiol 273:L1242-L1248, 1997.
26. Doyle MP, Galey WR, Walker BR: Reduced erythrocyte deformability alters pulmonary hemodynamics. J Appl Physiol 67:2593-2599, 1989.
27. Lieberthal W, LaRaia J, Valeri CR: Role of thromboxane in mediating the intrarenal vasoconstriction induced by unmodified stroma free hemoglobin in the isolated perfused rat kidney. Biomat Art Cells and Immob Biotech 20:663-667, 1992.
28. Wolgast M, Karlberg L, Kallskog O, Norlen BJ, Nygren K, Ojteg G: Hemodynamic alterations in ischaemic acute renal failure. Nephron 31:301-303, 1982.